![]()
|
Report Date : |
26.04.2008 |
IDENTIFICATION DETAILS
|
Correct Name : |
ESKAY ENGICHEM
PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Plot
No. - 3A, D-1, MIDC, Chinchwad, Pune - 411 019, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials
(as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
13.07.2005 |
|
|
|
|
Com. Reg. No.: |
21006 |
|
|
|
|
CIN No.: [Company Identification No.] |
U29299PN2005PTC021006 |
|
|
|
|
TAN
No.: [Tax
Deduction & Collection Account No.] |
PNEE01769F |
|
|
|
|
Legal Form : |
Private
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer
and Supplier of Bulk Drugs, Pharmaceutical and Speciality Chemicals. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
||||
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|||
|
|
|
|
|
|||
|
Maximum Credit Limit : |
USD
2094388 |
|
|||
|
|
|
|
|||
|
Status : |
Satisfactory
|
|
|||
|
|
|
|
|||
|
Payment Behaviour : |
Regular
|
|
|||
|
|
|
|
|||
|
Litigation : |
Clear |
|
|||
|
|
|
|
|||
|
Comments : |
Subject
is a well-established and reputed company having satisfactory track. Directors
are reported as experienced and respectable businessmen. Trade relations are
reported as fair. Business is active. Payments are usually correct and as per
commitments. The
company can be considered normal for business dealings at usual trade terms
and conditions. Management
declined financial and business details recent interactions with them. |
|
|||
LOCATIONS
|
Registered Office/ Factory : |
Plot
No.-3A, D-1, MIDC, Chinchwad, Pune – 411 019, Maharashtra, India |
|
Tel. No.: |
91-20-27474519
/27479665 / 27479665 / 27474519 |
|
Mobile No.: |
91-9371020676 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
(10000
Sq.fts.) Built – up Area / Plot area + 70000 sq. fts. |
|
Location : |
Leased
(Independent Building) |
DIRECTORS
|
Name : |
Mr.
Deepak S. Munot |
|
Designation : |
Director |
|
Date of Birth/Age : |
46
years |
|
Qualification : |
Post
Graduate |
|
Experience : |
24
years |
|
|
|
|
Name : |
Mr.
Dinesh Munot |
|
Designation : |
Director |
|
Date of Birth/Age : |
39
years |
|
Qualification : |
Graduate |
|
Experience : |
16
years |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer
and Supplier of Bulk Drugs, Pharmaceutical and Speciality Chemicals. |
|
|
|
|
Products : |
Crown
Ethers · 18-Crown-6 [17455-13-9] · 15-Crown -5 [33100-27-5] Bulk
Drugs, Pharmaceutical Intermediates & Specialty Chemicals · 2-Phenoxyisobutyric Acid [943-45-3] · Clofibric Acid [882-09-7] · Fenofibric Acid [42017-89-0] · 2-Indolinone i.e. Oxindole [59-48-3] · Inorganic Acids and Anhydrides · Phenols, Polyphenols, Ethers, Aldehydes, Ketones, Quinones · Row Materials for Pharmaceuticals · Phthalide [87-41-2] · 2-Indolinone i.e. Oxindole [59-48-3] · 4-(Dimethylamino)benzophenone [530-44-9] · 1,2,3-Trichloro-5-nitrobenzene [20098-48-0] · 6-Bromo-2-naphthol [15231-91-1] · 2-Propoxybenzoic acid [2100-31-4] · 2-(4-Aminophenyl)ethylamine [13472-00-9] · 4-(2-Aminoethyl)morpholine [2038-03-1] · 4-(3-Aminopropyl)morpholine [123-00-2] · 2-Hydroxybenzimidazole [615-16-7] · 5-Chloro-2-benzimidazolone [2034-23-3] · 2-Mercaptobenzoxazole [2382-96-9] · 2-(Methylthio)benzoxazole [13673-62-6] · 4-(Benzyloxy)phenylacetic acid [6547-53-1] · Glycoluril [496-48-8] · Substituted Benzoic acids & other products by Air-Oxidation |
|
|
|
|
Exports
: |
|
|
Products : |
Bulk
Drugs, Pharmaceutical Intermediates and Speciality Chemicals |
|
Countries : |
Japan,
Europe, South-East Asia (Taiwan) |
|
|
|
|
Import : |
|
|
Countries : |
China |
|
|
|
|
Terms : |
|
|
Selling : |
Cash
and Credit |
|
|
|
|
Purchasing : |
Cash
and Credit |
GENERAL INFORMATION
|
Suppliers : |
Ř
AMB
And Company Ř
Amit
P Punde Ř
Anand
Industries Ř
Bora
And Company Ř
BSNL Ř
Chemo
Fab Industries Ř
Chemo
Test Laboratories Ř
Deore
Transport Service Ř
Dhananjay
Traders Ř
Efficient
Industrial Services Ř
Enopeck
Security Seals (India) Ř
Esteem
Enginnering Works Ř
Excel
Engineering And Consultant Ř
Fine
Lasercut Private Limited Ř
Fit
Fast Engineering Ř
Geo
Remedies Ř
H
N Corporation Ř
Hari
Trading Company Ř
Industrial
Coating Ř
Jyoti
Heat – Treat Industries Ř
Konark
Technocomp Private Limited Ř
Krypton
Powder Paints Private Limited Ř
Kunusha
Steels Ř
Lakshmi
Enterprises Ř
M
M Traders Ř
M
K Die Works Ř
Marpol
Private Limited Ř
Mittal
Precision Steel Tubes Private Limited Ř
New
Star Chemicals Ř
Nutraplus
Products (India) Limited Ř
Perfect
Courier Services Ř
Phoenix
Enterprises Ř
Precise
Springs Ř
Pure
Filter Systems Ř
Ravi
Corporation Ř
Renuka
Enterprises Ř
Rohit
Engineering Works Ř
Roopali
Coating Ř
Sai
– Tech Scientific Ř
Sanjivani
Enterprises Ř
Sankalp
Steeltech Corp Private Limited Ř
Sapana
Galvanizers Ř
Sharada
Industries Ř
Shree
Ajinkya Electrical Company Ř
Shree
Sadguru Entp Ř
Shripad
Lubricants Ř
Sigma
Gases Ř
Star
Delt Engineers Ř
Suresh
Tukaram Gavhane Ř
Suttatti
Enpt Private Limited Ř
SVS
Chemical Corporation Ř
The
Printing People Ř
TUV
India Limited Ř
Venus
Fabco Ř
Vishwakarma
Engineering Works Ř
Yashwant
Engineers |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Customers : |
Ř
S
Nihar Exports Ř
Lucy
Switchgear Ř
Suzlon
Energy Limited Ř
Suzlon
Windfarm Services Private Limited, Tamilnadu Ř
Suzlon
Windfarm Services Private Limited, Satara Ř
Alpha
Foam Limited (Chakan Division) Ř
Automag
India Private Limited Chakan Unit Ř
D
Maniar And Brothers Ř
Force
Motors Limited Ř
Force
Motors Limited (Pithampur Unit) Ř
Thermax
Limited – Chemical Division Ř
Sanket
Pharmaceuticals Limited Ř
Panchsheel
Organica Limited Ř
Deepak
Nitrite Limited Ř
Hildose |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
20 |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Bankers : |
Ř
Bank
of Maharashtra, Navi Peth, Pune-411030, Maharashtra, India Ř
Citibank
N.A., Pune, Maharashtra, India Ř
Central
Bank of India |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Facilities: |
SECURED LOANS
UNSECURED LOAN
|
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Banking Relations : |
Satisfactory
|
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Auditors : |
AMB
& Company Chartered
Accountants |
CAPITAL STRUCTURE
Authorised
Capital :
|
No.
of Shares |
Type |
Value |
Amount |
|
100000 |
Equity Shares |
Rs.10/- each |
Rs.1.000 million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10000 |
Equity Shares |
Rs.10/- each |
Rs.0.100 million |
FINANCIAL DATA
[all figures are in Rupees
Millions]
ABRIDGED BALANCE SHEET
|
SOURCES OF FUNDS |
|
31.03.2006 |
|
|
SHAREHOLDERS
FUNDS |
|
|
|
|
1]
Share Capital |
|
0.100 |
|
|
2]
Share Application Money |
|
0.000 |
|
|
3]
Reserves & Surplus |
|
0.423 |
|
|
4]
(Accumulated Losses) |
|
0.000 |
|
|
NETWORTH |
|
0.523 |
|
|
LOAN
FUNDS |
|
|
|
|
1]
Secured Loans |
|
1.112 |
|
|
2]
Unsecured Loans |
|
9.805 |
|
|
TOTAL BORROWING |
|
10.917 |
|
|
DEFERRED
TAX LIABILITIES |
|
0.000 |
|
|
TOTAL |
|
11.441 |
|
|
|
|
|
|
|
APPLICATION
OF FUNDS |
|
|
|
|
|
|
|
|
|
FIXED
ASSETS [Net Block] |
|
2.723 |
|
|
Capital
work-in-progress |
|
0.000 |
|
|
|
|
|
|
|
INVESTMENT |
|
0.000 |
|
|
DEFERREX
TAX ASSETS |
|
0.097 |
|
|
|
|
|
|
|
CURRENT
ASSETS, LOANS & ADVANCES |
|
|
|
|
|
Inventories |
|
4.530 |
|
|
Sundry
Debtors |
|
5.261 |
|
|
Cash
& Bank Balances |
|
1.869 |
|
|
Other
Current Assets |
|
0.553 |
|
|
Loans
& Advances |
|
0.866 |
|
Total Current
Assets |
|
13.081 |
|
|
Less : CURRENT LIABILITIES &
PROVISIONS |
|
|
|
|
|
Current
Liabilities |
|
|
|
|
Provisions |
|
4.492 |
|
Total Current
Liabilities |
|
4.492 |
|
|
Net Current Assets |
|
8.589 |
|
|
|
|
|
|
|
MISCELLANEOUS
EXPENSES |
|
0.030 |
|
|
|
|
|
|
|
TOTAL |
|
11.441 |
|
PROFIT & LOSS ACCOUNT
|
PARTICULARS |
|
31.03.2006 |
|
|
Sales
Turnover |
|
22.090 |
|
|
Other Income |
|
0.094 |
|
|
Total
Income |
|
22.185 |
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
0.573 |
|
|
Provision for Taxation |
|
0.150 |
|
|
Profit/(Loss) After Tax |
|
0.423 |
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
Other administrative expenses |
|
2.301 |
|
|
Commission on sale |
|
0.000 |
|
|
Bank interest |
|
0.000 |
|
|
Salary to others |
|
0.000 |
|
|
Interest to other |
|
0.000 |
|
|
Depreciation |
|
0.203 |
|
|
Purchases |
|
11.917 |
|
|
Direct expenses |
|
4.908 |
|
|
Other manufacturing expenses |
|
2.280 |
|
Total
Expenditure |
|
21.611 |
|
KEY RATIOS
|
PARTICULARS |
|
|
31.03.2006 |
|
PAT /
Total Income |
(%) |
|
1.90 |
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
|
2.59 |
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
|
3.62 |
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
|
1.09 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
29.46 |
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
2.29 |
LOCAL AGENCY FURTHER INFORMATION
HISTORY:
Originally
started as Eskay Industries in year 1973 as a Proprietory Concern of Mr. S. L.
Munot. Converted into a Private Limited Company on 13.07.2005 having Company
Registration No. 021006.
TRADE
REFERENCES – LOCAL:
· Dishman Pharmaceuticals
· Deepak Nitrite Limited, Mumbai
FIXED ASSETS:
Ř
Plant
and machinery
Ř
Electric
installation
Ř
Building
Ř
Vehicles
Ř
Furniture
and fixtures
Ř
Computer
OTHER INFORMATION:
ESKAY
INDUSTRIES (PROP. MR. DEEPAK S. MUNOT)
ABRIDGED BALANCE SHEET
[Rs. In millions]
|
SOURCES OF FUNDS |
|
28.09.2005 |
|
|
SHAREHOLDERS
FUNDS |
|
|
|
|
1]
Share Capital |
|
0.000 |
|
|
2]
Share Application Money |
|
0.000 |
|
|
3]
Reserves & Surplus |
|
0.000 |
|
|
4]
(Accumulated Losses) |
|
0.000 |
|
|
NETWORTH |
|
0.000 |
|
|
LOAN
FUNDS |
|
|
|
|
1]
Secured Loans |
|
0.000 |
|
|
2]
Unsecured Loans |
|
8.890 |
|
|
TOTAL BORROWING |
|
8.890 |
|
|
DEFERRED
TAX LIABILITIES |
|
0.000 |
|
|
TOTAL |
|
8.890 |
|
|
|
|
|
|
|
APPLICATION
OF FUNDS |
|
|
|
|
|
|
|
|
|
FIXED
ASSETS [Net Block] |
|
2.242 |
|
|
Capital
work-in-progress |
|
0.000 |
|
|
|
|
|
|
|
INVESTMENT |
|
0.000 |
|
|
DEFERREX
TAX ASSETS |
|
0.000 |
|
|
|
|
|
|
|
CURRENT
ASSETS, LOANS & ADVANCES |
|
|
|
|
|
Inventories |
|
0.000 |
|
|
Sundry
Debtors |
|
4.006 |
|
|
Cash
& Bank Balances |
|
0.838 |
|
|
Other
Current Assets |
|
0.507 |
|
|
Loans
& Advances |
|
4.558 |
|
Total Current
Assets |
|
9.909 |
|
|
Less : CURRENT LIABILITIES &
PROVISIONS |
|
|
|
|
|
Current
Liabilities |
|
|
|
|
Provisions |
|
3.262 |
|
Total Current
Liabilities |
|
3.262 |
|
|
Net Current Assets |
|
6.647 |
|
|
|
|
|
|
|
MISCELLANEOUS
EXPENSES |
|
0.000 |
|
|
|
|
|
|
|
TOTAL |
|
8.890 |
|
PROFIT & LOSS ACCOUNT
[Rs. In millions]
|
PARTICULARS |
|
28.09.2005 |
|
|
Sales
Turnover |
|
17.192 |
|
|
Other Income |
|
0.000 |
|
|
Total
Income |
|
17.192 |
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
1.180 |
|
|
Provision for Taxation |
|
0.000 |
|
|
Profit/(Loss) After Tax |
|
1.180 |
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
Audit and tax consultation fees |
|
0.012 |
|
|
Books and periodicals |
|
0.005 |
|
|
Advertisement |
|
0.002 |
|
|
Bank charges |
|
0.012 |
|
|
Telecommunication expenses |
|
0.070 |
|
|
Freight outward |
|
2.150 |
|
|
Courier expenses |
|
0.003 |
|
|
Entertainment expenses |
|
0.010 |
|
|
Legal and professional fees |
|
0.020 |
|
|
Bad debts |
|
0.000 |
|
|
Repairs and maintenance |
|
0.132 |
|
|
Other administrative expenses |
|
0.131 |
|
|
Commission on sale |
|
0.316 |
|
|
Bank interest |
|
0.026 |
|
|
Salary to others |
|
0.333 |
|
|
Interest to other |
|
0.592 |
|
|
Depreciation |
|
0.182 |
|
Total
Expenditure |
|
4.178 |
|
KEY RATIOS
|
PARTICULARS |
|
|
28.09.2005 |
|
PAT /
Total Income |
(%) |
|
6.86 |
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
|
6.86 |
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
|
9.71 |
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
|
0.00 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
0.00 |
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
3.03 |
WEBSITE
DETAILS:
A professionally managed company, subject is
a well known speciality chemicals manufacturers and suppliers of Pharmaceutical
Chemicals, Bulk Drugs, Pharmaceutical Intermediates and Specialty Chemicals.
Company
Profile
Subject
is a leading manufacturer and supplier of Bulk Drugs, Pharmaceutical Chemicals
and Specialty Chemicals.
With rudimentary understanding of the needs and wants of their clients, they
offer products that suit both their requirements and budget. A thorough
analysis of their clients' needs and provision of customized services sets them
apart from their competitors. Their principal aim is to not only meet but
exceed their clients' expectations through their expertise.
They have never compromised on quality and have successfully achieved a high
level of customer satisfaction resulting in long-lasting relations. They have
made an indelible imprint on the minds of their clients all over the country by
offering pro-active services.
Strengths
Excellence
Quality consistency and excellent after
sales service in best possible way their main concern. All the raw materials
are inspected and regular checks are undertaken on the products. Their team of
experts maintains a strict vigil on the manufacturing process to ensure that
all the products are without any defects.
Infrastructure
The credit for their phenomenal growth goes
to their sound infrastructure that is equipped with state-of-the-production
unit. Their dedicated and diligent workforce helps them abreast with the newer
trends in market. They possess requisite technology and hi-tech machines for
yielding excellent results. Their team of chemists and professionals are
engaged in coming out with high quality chemicals.
Laboratory
They possess a state-of-the-art laboratory.
Their laboratories are equipped with sophisticated analytical and performance
testing equipment to ensure their products meet the performance requirements
needed by their customers. Considerable research is carried out, both in the
development of existing products as well as into new chemical entities and
products. Their scientists are pivotal in bringing forth authentic and pure
chemicals.
Customer Satisfaction
They have maintained long lasting relations
with their clients by offering them customized products of international
standard. Their persistent efforts have earned them a loyal clientele across
India and overseas.
Clients
They have been exporting to world's best
markets and have created a worldwide presence. They have won the trust and
confidence of their customers because of their customer friendly services and
their ability to fulfil all their commitments on time.
CMT REPORT [Corruption, Money laundering
& Terrorism]
The
Public Notice information has been collected from various sources including but
not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the subject of any
formal or informal allegations, prosecutions or other official proceeding for
making any prohibited payments or other improper payments to government
officials for engaging in prohibited transactions or with designated parties.
3] Asset
Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation
with Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation
Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM
as part of its Due Diligence do provide comments on Corporate Governance to
identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject
is not known to have contravened any existing local laws, regulations or
policies that prohibit, restrict or otherwise affect the terms and conditions
that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US
Dollar |
1 |
Rs.40.18 |
|
UK
Pound |
1 |
Rs.79.25 |
|
Euro |
1 |
Rs.62.90 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial condition
(40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses
an extremely sound financial base with the strongest capability for timely
payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses
adequate working capital. No caution needed for credit transaction. It has
above average (strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial
& operational base are regarded healthy. General unfavourable factors will
not cause fatal effect. Satisfactory capability for payment of interest and
principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable
& favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse
factors are apparent. Repayment of interest and principal sums in default or
expected to be in default upon maturity |
Limited with full security |
|
<10 |
C |
Absolute
credit risk exists. Caution needed to be exercised |
Credit not recommended |
|
NR |
In view
of the lack of information, we have no basis upon which to recommend credit
dealings |
No Rating |
|